Business
Cytophage Secures Health Canada Validation for OvaPhage and PhageFend Products for use in Food Safety
(TheNewswire) Cytophage receives Letters of No Objection (LONO) from Health Canada for ...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":"Cytophage Secures Health Canada Validation for OvaPhage and PhageFend Products for use in Food Safety\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Cytophage receives Letters of No\nObjection (LONO) from Health Canada for two of its cutting-edge\nbacteriophage products\n \n\n\n\n\n\n Regulatory milestone accelerates\nCytophage’s path to commercialization and broader market\naccess\n \n\n\n\n\n\n Canada aligns with the EU and US in\naccepting phage technology, advancing antibiotic-free food\nsolutions\n \n\n\n\n\n\n WINNIPEG –\n \n\n TheNewswire -\n \n\n August 25, 2025\n \n\n —\nCytophage Technologies Ltd. (“Cytophage” or the “Company”)\n(TSXV: CYTO, FSE: 70G) today announced that it is in receipt of two\nLetters of No Objection (“LONO”) from Health Canada regarding its\nOvaPhage egg surface product and its PhageFend food surface product,\nmarking a major regulatory milestone that will help pave the way for\nthe introduction of innovative, science-driven solutions to enhance\nfood safety in the Canadian market.\n \n\n\n\n The LONO validations affirm the safety and efficacy of\nbacteriophage technology for use in food processing, with OvaPhage now\nin the final stages of development and advancing towards\ncommercialization.\n \n\n\n\n Phage treatments present an alternative to antibiotics\nwhich are\n \n\n known contributors to global\nantimicrobial resistance (“AMR”). With these validations, Canada\nis recognizing and accepting phage technology for food safety and\nantibiotic-free food options. The LONO notifications are also a\ncrucial step forward in granting phage products market access under a\nregulated path in Canada.\n \n\n\n\n “This milestone underscores our unwavering commitment\nto eliminating bacterial diseases and infections,” said Dr. Steven\nTheriault, CEO of Cytophage. “We are proud to lead the way in\ndemonstrating that phage-based solutions can be safe and effective\ntools for enhancing food safety and security, especially in light of\nthe current\n \n\n Salmonella\n \n\n outbreaks related to pistachio and\nsalami contamination in Canada. By expanding access to our innovative\nphage products, we aim to significantly reduce reliance on antibiotics\nin food systems—off...